Osteoporosis, a growing epidemic among women in North America, Europe, and Japan, is a painful, costly disease that has presented a treatment challenge to healthcare professionals. Until recently, therapies have focused on agents that slow bone resorption, and have had only limited success at increasing bone mass. However, exciting new developments are on the verge of changing the treatment of this debilitating disorder. Two anabolic agents, the parathyroid hormone (PTH) and the fluoride ion, show tremendous promise as tools for building and retaining bone - with no adverse side effects. Anabolic Treatments for Osteoporosis is a comprehensive account of the latest studies that have been carried out on these two agents, and a thorough assessment of their prospects as osteoporosis therapeutics. This unique book combines basic science and up-to-date clinical data to present a complete picture of this breakthrough in the treatment of a globally significant health issue.
A concise review of the current knowledge of osteoporosis, aimed at the busy pratitioner who is increasingly involved in the management of osteoporosis and who wants accurate and practical answers to questions that arise in daily clinical ...
Providing a comprehensive review of short-and long-term adverse events of both antiresorptive and anabolic drugs, this practical guide updates the clinician on the pathophysiology of osteoporosis and the principles behind our present and ...
William N. Taylor, M.D.. 2. Johnson, C.A. Use of androgens in patients with renal failure. Semin. Dial. ... Akmal, M., D.A. Goldstein, O.A. Kletzky, et al. Hyperparathyroidism and hypotestosteronemia of acute renal failure.
This issue of Endocrinology and Metabolism Clinics provides a comprehensive review of osteoporosis written by the world's leading experts.
This book provides a practical overview of osteoporosis for the wide spectrum of clinicians that might encounter the osteoporotic patient.
This second edition brings on board John Bilezikian and Dirk Vanderschueren as editors with Eric Orwoll. The table of contents is more than doubling with 58 planned chapters. The format is larger – 8.5 x 11.
This book provides readers a fundamental insight into the basic properties of the pharmaceutical agents used in the treatment of osteoporosis.
Pragmatic and reader-friendly, Osteoporosis: A Clinical Casebook is an excellent resource for primary care providers, endocrinologists, rheumatologists, and other clinicians caring for patients with this disease.
General care management measures are similar to those previously described for LS. ... The standardized incidence ratio of vulvar cancer in women has been estimated to double in women with LP [33], ... more likely to recur [34].
The purpose of this book is to show several reviews and original investigations related with osteoporosis.